Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

William Markesbery

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Living Beings

Rats

Physiology

Phenomena

Procedures

Immunohistochemistry

Concepts & Ideas

Longitudinal Studies

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
54
Lovell, Mark
43
Butterfield, Allan
25
Smith, Charles
25
Keller, Jeff
24
Schmitt, Frederick
20
Ehmann, WD
18
Kryscio, Richard
18
Snowdon, David
18
Montine, Thomas
16
Wekstein, David
14
Aksenov, Michael
12
Mattson, Mark
12
Xie, Chengsong
12
Petrovitch, Helen
12
Ross, Webster

Sign-in to see all Coauthors

Publications

TOP 3
Nelson P T; Kryscio R J; Jicha G A; Abner E L; Schmitt F A; Xu L O; Cooper G; Smith C D; Markesbery W R
Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies.
Iacono D; Markesbery W R; Gross M; Pletnikova O; Rudow G; Zandi P; Troncoso J C
The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.
Nelson Peter T; Abner Erin L; Schmitt Frederick A; Kryscio Richard J; Jicha Gregory A; Santacruz Karen; Smith Charles D; Patel Ela; Markesbery William R
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of William Markesbery (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nelson P T; Kryscio R J; Jicha G A; Abner E L; Schmitt F A; Xu L O; Cooper G; Smith C D; Markesbery W R
Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies.
Neurology 2009;73(14):1127-33.
2009: Iacono D; Markesbery W R; Gross M; Pletnikova O; Rudow G; Zandi P; Troncoso J C
The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.
Neurology 2009;73(9):665-73.
2009: Nelson Peter T; Abner Erin L; Schmitt Frederick A; Kryscio Richard J; Jicha Gregory A; Santacruz Karen; Smith Charles D; Patel Ela; Markesbery William R
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
Journal of neuropathology and experimental neurology 2009;68(7):774-84.
2009: Markesbery William R; Jicha Gregory A; Liu Huaichen; Schmitt Frederick A
Lewy body pathology in normal elderly subjects.
Journal of neuropathology and experimental neurology 2009;68(7):816-22.
2009: Price Joseph L; McKeel Daniel W; Buckles Virginia D; Roe Catherine M; Xiong Chengjie; Grundman Michael; Hansen Lawrence A; Petersen Ronald C; Parisi Joseph E; Dickson Dennis W; Smith Charles D; Davis Daron G; Schmitt Frederick A; Markesbery William R; Kaye Jeffrey; Kurlan Roger; Hulette Christine; Kurland Brenda F; Higdon Roger; Kukull Walter; Morris John C
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.
Neurobiology of aging 2009;30(7):1026-36.
2009: Reed Tanea T; Pierce William M; Markesbery William R; Butterfield D Allan
Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Brain research 2009;1274():66-76.
2009: Lovell Mark A; Xiong Shuling; Lyubartseva Ganna; Markesbery William R
Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice.
Free radical biology & medicine 2009;46(11):1527-33.
2009: Nelson Peter T; Smith Charles D; Abner Erin A; Schmitt Frederick A; Scheff Stephen W; Davis Gregory J; Keller Jeffrey N; Jicha Gregory A; Davis Daron; Wang-Xia Wang; Hartman Adria; Katz Douglas G; Markesbery William R
Human cerebral neuropathology of Type 2 diabetes mellitus.
Biochimica et biophysica acta 2009;1792(5):454-69.
2009: Mortimer James A; Snowdon David A; Markesbery William R
The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology.
Alzheimer disease and associated disorders 2009;23(2):152-7.
2009: Studzinski Christa M; Li Feng; Bruce-Keller Annadora J; Fernandez-Kim Sun Ok; Zhang Le; Weidner Adam M; Markesbery William R; Murphy M Paul; Keller Jeffrey N
Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice.
Journal of neurochemistry 2009;108(4):860-6.
2009: Nelson Peter T; Abner Erin L; Scheff Stephen W; Schmitt Frederick A; Kryscio Richard J; Jicha Gregory A; Smith Charles D; Patel Ela; Markesbery William R
Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
Neuroscience letters 2009;450(3):336-9.
2009: Nelson Peter T; Kryscio Richard J; Abner Erin L; Schmitt Frederick A; Jicha Gregory A; Mendiondo Marta S; Cooper Greg; Smith Charles B; Markesbery William R
Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB.
Journal of Alzheimer's disease : JAD 2009;16(1):29-34.
2009: Nelson Peter T; Braak Heiko; Markesbery William R
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.
Journal of neuropathology and experimental neurology 2009;68(1):1-14.
2009: Grear Karrie E; Ling I-Fang; Simpson James F; Furman Jennifer L; Simmons Christopher R; Peterson Shawn L; Schmitt Frederick A; Markesbery William R; Liu Qiang; Crook Julia E; Younkin Steven G; Bu Guojun; Estus Steven
Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.
Molecular neurodegeneration 2009;4():46.
2008: Smith C D; Chebrolu H; Markesbery W R; Liu J
Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease.
Neurological research 2008;30(10):1091-6.
2008: Dong Jiang; Robertson J David; Markesbery William R; Lovell Mark A
Serum zinc in the progression of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2008;15(3):443-50.
2008: Abdul Hafiz Mohmmad; Sultana Rukhsana; St Clair Daret K; Markesbery William R; Butterfield D Allan
Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.
Free radical biology & medicine 2008;45(10):1420-5.
2008: Petrovitch Helen; Ross G Webster; He Qimei; Uyehara-Lock Jane; Markesbery William; Davis Daron; Nelson James; Masaki Kamal; Launer Lenore; White Lon R
Characterization of Japanese-American men with a single neocortical AD lesion type.
Neurobiology of aging 2008;29(10):1448-55.
2008: Launer Lenore J; Petrovitch Helen; Ross G Webster; Markesbery William; White Lon R
AD brain pathology: vascular origins? Results from the HAAS autopsy study.
Neurobiology of aging 2008;29(10):1587-90.
2008: Shao Changxing; Xiong Shuling; Li Guo-Min; Gu Liya; Mao Guogen; Markesbery William R; Lovell Mark A
Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain.
Free radical biology & medicine 2008;45(6):813-9.
2008: Tang Sung-Chun; Lathia Justin D; Selvaraj Pradeep K; Jo Dong-Gyu; Mughal Mohamed R; Cheng Aiwu; Siler Dominic A; Markesbery William R; Arumugam Thiruma V; Mattson Mark P
Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.
Experimental neurology 2008;213(1):114-21.
2008: Sonnen Joshua A; Breitner John C; Lovell Mark A; Markesbery William R; Quinn Joseph F; Montine Thomas J
Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.
Free radical biology & medicine 2008;45(3):219-30.
2008: Mortimer James A; Snowdon David A; Markesbery William R
Small head circumference is associated with less education in persons at risk for Alzheimer disease in later life.
Alzheimer disease and associated disorders 2008;22(3):249-54.
2008: Lovell M A; Lynn B C; Xiong S; Quinn J F; Kaye J; Markesbery W R
An aberrant protein complex in CSF as a biomarker of Alzheimer disease.
Neurology 2008;70(23):2212-8.
2008: Reed Tanea; Perluigi Marzia; Sultana Rukhsana; Pierce William M; Klein Jon B; Turner Delano M; Coccia Raffaella; Markesbery William R; Butterfield D Allan
Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
Neurobiology of disease 2008;30(1):107-20.
2008: Lovell Mark A; Markesbery William R
Oxidatively modified RNA in mild cognitive impairment.
Neurobiology of disease 2008;29(2):169-75.
2008: Jicha G A; Abner E; Schmitt F A; Cooper G E; Stiles N; Hamon R; Carr S; Smith C D; Markesbery W R
Clinical features of mild cognitive impairment differ in the research and tertiary clinic settings.
Dementia and geriatric cognitive disorders 2008;26(2):187-92.
2007: Nelson Peter T; Jicha Gregory A; Schmitt Frederick A; Liu Huaichen; Davis Daron G; Mendiondo Marta S; Abner Erin L; Markesbery William R
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.
Journal of neuropathology and experimental neurology 2007;66(12):1136-46.
2007: Youn HyeSook; Ji Inhae; Ji Hanlee P; Markesbery William R; Ji Tae H
Under-expression of Kalirin-7 Increases iNOS activity in cultured cells and correlates to elevated iNOS activity in Alzheimer's disease hippocampus.
Journal of Alzheimer's disease : JAD 2007;12(3):271-81.
2007: Tyas Suzanne L; Snowdon David A; Desrosiers Mark F; Riley Kathryn P; Markesbery William R
Healthy ageing in the Nun Study: definition and neuropathologic correlates.
Age and ageing 2007;36(6):650-5.
2007: Lovell Mark A; Markesbery William R
Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
Journal of neuroscience research 2007;85(14):3036-40.
2007: Murphy M Paul; Beckett Tina L; Ding Qunxing; Patel Ela; Markesbery William R; St Clair Daret K; LeVine Harry; Keller Jeffrey N
Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.
Neurobiology of disease 2007;27(3):301-11.
2007: Markesbery William R; Lovell Mark A
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
Archives of neurology 2007;64(7):954-6.
2007: Smith Charles D; Chebrolu Himachandra; Wekstein David R; Schmitt Frederick A; Markesbery William R
Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly.
Neurobiology of aging 2007;28(7):1075-87.
2007: Youn HyeSook; Jeoung MyoungKun; Koo YongBum; Ji Hanlee; Markesbery William R; Ji Inhae; Ji Tae H
Kalirin is under-expressed in Alzheimer's disease hippocampus.
Journal of Alzheimer's disease : JAD 2007;11(3):385-97.
2007: Butterfield D Allan; Reed Tanea T; Perluigi Marzia; De Marco Carlo; Coccia Raffaella; Keller Jeffrey N; Markesbery William R; Sultana Rukhsana
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
Brain research 2007;1148():243-8.
2007: Smith C D; Chebrolu H; Wekstein D R; Schmitt F A; Jicha G A; Cooper G; Markesbery W R
Brain structural alterations before mild cognitive impairment.
Neurology 2007;68(16):1268-73.
2007: Xiong Shuling; Markesbery William R; Shao Changxing; Lovell Mark A
Seleno-L-methionine protects against beta-amyloid and iron/hydrogen peroxide-mediated neuron death.
Antioxidants & redox signaling 2007;9(4):457-67.
2007: Neumann Manuela; Mackenzie Ian R; Cairns Nigel J; Boyer Philip J; Markesbery William R; Smith Charles D; Taylor J Paul; Kretzschmar Hans A; Kimonis Virginia E; Forman Mark S
TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.
Journal of neuropathology and experimental neurology 2007;66(2):152-7.
2007: Lovell Mark A; Markesbery William R
Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease.
Nucleic acids research 2007;35(22):7497-504.
2007: Weissman Lior; Jo Dong-Gyu; Sørensen Martin M; de Souza-Pinto Nadja C; Markesbery William R; Mattson Mark P; Bohr Vilhelm A
Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment.
Nucleic acids research 2007;35(16):5545-55.
2007: Mao Guogen; Pan Xiaoyu; Zhu Bei-Bei; Zhang Yanbin; Yuan Fenghua; Huang Jian; Lovell Mark A; Lee Maxwell P; Markesbery William R; Li Guo-Min; Gu Liya
Identification and characterization of OGG1 mutations in patients with Alzheimer's disease.
Nucleic acids research 2007;35(8):2759-66.
2006: Ross G Webster; Abbott Robert D; Petrovitch Helen; Tanner Caroline M; Davis Daron G; Nelson James; Markesbery William R; Hardman John; Masaki Kamal; Launer Lenore; White Lon R
Association of olfactory dysfunction with incidental Lewy bodies.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2062-7.
2006: Markesbery William R; Lovell Mark A
DNA oxidation in Alzheimer's disease.
Antioxidants & redox signaling 2006;8(11-12):2039-45.
2006: Sultana Rukhsana; Boyd-Kimball Debra; Poon H Fai; Cai Jian; Pierce William M; Klein Jon B; Merchant Michael; Markesbery William R; Butterfield D Allan
Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
Neurobiology of aging 2006;27(11):1564-76.
2006: Lovell Mark A; Markesbery William R
Amyloid beta peptide, 4-hydroxynonenal and apoptosis.
Current Alzheimer research 2006;3(4):359-64.
2006: Williams Taufika Islam; Lynn Bert C; Markesbery William R; Lovell Mark A
Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.
Neurobiology of aging 2006;27(8):1094-9.
2006: Markesbery William R
Commentary on "Vascular cognitive impairment: Today and tomorrow".
Alzheimer's & dementia : the journal of the Alzheimer's Association 2006;2(3):205-6.
2006: Shao Changxing; Roberts Kelly N; Markesbery William R; Scheff Stephen W; Lovell Mark A
Oxidative stress in head trauma in aging.
Free radical biology & medicine 2006;41(1):77-85.
2006: Smith J L; Xiong S; Markesbery W R; Lovell M A
Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
Neuroscience 2006;140(3):879-88.
2006: Lovell Mark A; Geiger Hartmut; Van Zant Gary E; Lynn Bert C; Markesbery William R
Isolation of neural precursor cells from Alzheimer's disease and aged control postmortem brain.
Neurobiology of aging 2006;27(7):909-17.
2006: Sultana Rukhsana; Boyd-Kimball Debra; Poon H Fai; Cai Jain; Pierce William M; Klein Jon B; Markesbery William R; Zhou Xiao Zhen; Lu Kun Ping; Butterfield D Allan
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis.
Neurobiology of aging 2006;27(7):918-25.
2006: Forman Mark S; Mackenzie Ian R; Cairns Nigel J; Swanson Eric; Boyer Philip J; Drachman David A; Jhaveri Bharati S; Karlawish Jason H; Pestronk Alan; Smith Thomas W; Tu Pang-Hsien; Watts Giles D J; Markesbery William R; Smith Charles D; Kimonis Virginia E
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.
Journal of neuropathology and experimental neurology 2006;65(6):571-81.
2006: Ding Qunxing; Dimayuga Edgardo; Markesbery William R; Keller Jeffrey N
Proteasome inhibition induces reversible impairments in protein synthesis.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(8):1055-63.
2006: Smith Charles D; Wekstein David R; Markesbery William R; Frye Cheryl A
3alpha,5alpha-THP: a potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia.
Psychopharmacology 2006;186(3):481-5.
2006: Bing Guoying; Nguyen Xuan V; Liu Mei; Markesbery William R; Sun Anyang
Biophysical and biochemical characterization of the intrinsic fluorescence from neurofibrillary tangles.
Neurobiology of aging 2006;27(6):823-30.
2006: Lovell Mark A; Smith Jennifer L; Markesbery William R
Elevated zinc transporter-6 in mild cognitive impairment, Alzheimer disease, and pick disease.
Journal of neuropathology and experimental neurology 2006;65(5):489-98.
2006: Ding Qunxing; Markesbery William R; Cecarini Valentina; Keller Jeffrey N
Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease.
Neurochemical research 2006;31(5):705-10.
2006: Anantharaman Muthuswamy; Tangpong Jitbanjong; Keller Jeffery N; Murphy Michael P; Markesbery William R; Kiningham Kelley K; St Clair Daret K
Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.
The American journal of pathology 2006;168(5):1608-18.
2006: Butterfield D Allan; Poon H Fai; St Clair Daret; Keller Jeffery N; Pierce William M; Klein Jon B; Markesbery William R
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
Neurobiology of disease 2006;22(2):223-32.
2006: Liu Mei; Sun Anyang; Shin Eun-Joo; Liu Xianxi; Kim Sang-Geon; Runyons Cecil R; Markesbery William; Kim Hyoung-Chun; Bing Guoying
Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin.
The European journal of neuroscience 2006;23(8):2027-34.
2006: Sultana Rukhsana; Poon H Fai; Cai Jian; Pierce William M; Merchant Michael; Klein Jon B; Markesbery William R; Butterfield D Allan
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.
Neurobiology of disease 2006;22(1):76-87.
2006: Espinosa Patricio S; Kryscio Richard J; Mendiondo Marta S; Schmitt Fred A; Wekstein David R; Markesbery William R; Smith Charles D
Alzheimer's disease and head circumference.
Journal of Alzheimer's disease : JAD 2006;9(1):77-80.
2006: Kryscio R J; Schmitt F A; Salazar J C; Mendiondo M S; Markesbery W R
Risk factors for transitions from normal to mild cognitive impairment and dementia.
Neurology 2006;66(6):828-32.
2006: Mohmmad Abdul Hafiz; Sultana Rukhsana; Keller Jeffrey N; St Clair Daret K; Markesbery William R; Butterfield D Allan
Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Journal of neurochemistry 2006;96(5):1322-35.
2006: Wang Jianquan; Markesbery William R; Lovell Mark A
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment.
Journal of neurochemistry 2006;96(3):825-32.
2006: Markesbery William R; Schmitt Frederick A; Kryscio Richard J; Davis Daron G; Smith Charles D; Wekstein David R
Neuropathologic substrate of mild cognitive impairment.
Archives of neurology 2006;63(1):38-46.
2005: White Lon; Small Brent J; Petrovitch Helen; Ross G Webster; Masaki Kamal; Abbott Robert D; Hardman John; Davis Daron; Nelson James; Markesbery William
Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study.
Journal of geriatric psychiatry and neurology 2005;18(4):224-7.
2005: Markesbery William R; Kryscio Richard J; Lovell Mark A; Morrow Jason D
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
Annals of neurology 2005;58(5):730-5.
2005: Russo Roberta; Borghi Roberta; Markesbery William; Tabaton Massimo; Piccini Alessandra
Neprylisin decreases uniformly in Alzheimer's disease and in normal aging.
FEBS letters 2005;579(27):6027-30.
2005: Ding Qunxing; Markesbery William R; Chen Qinghua; Li Feng; Keller Jeffrey N
Ribosome dysfunction is an early event in Alzheimer's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(40):9171-5.
2005: Piccini Alessandra; Russo Claudio; Gliozzi Alessandra; Relini Annalisa; Vitali Antonella; Borghi Roberta; Giliberto Luca; Armirotti Andrea; D'Arrigo Cristina; Bachi Angela; Cattaneo Angela; Canale Claudio; Torrassa Silvia; Saido Takaomi C; Markesbery William; Gambetti Pierluigi; Tabaton Massimo
beta-amyloid is different in normal aging and in Alzheimer disease.
The Journal of biological chemistry 2005;280(40):34186-92.
2005: Lovell Mark A; Markesbery William R
Ectopic expression of Musashi-1 in Alzheimer disease and Pick disease.
Journal of neuropathology and experimental neurology 2005;64(8):675-80.
2005: Wang J; Xiong S; Xie C; Markesbery W R; Lovell M A
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.
Journal of neurochemistry 2005;93(4):953-62.
2005: Keller J N; Schmitt F A; Scheff S W; Ding Q; Chen Q; Butterfield D A; Markesbery W R
Evidence of increased oxidative damage in subjects with mild cognitive impairment.
Neurology 2005;64(7):1152-6.
2005: Riley Kathryn P; Snowdon David A; Desrosiers Mark F; Markesbery William R
Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.
Neurobiology of aging 2005;26(3):341-7.
2005: Ertekin-Taner Nilüfer; Ronald James; Feuk Lars; Prince Jonathan; Tucker Michael; Younkin Linda; Hella Maria; Jain Shushant; Hackett Alyssa; Scanlin Leah; Kelly Jason; Kihiko-Ehman Muthoni; Neltner Matthew; Hersh Louis; Kindy Mark; Markesbery William; Hutton Michael; de Andrade Mariza; Petersen Ronald C; Graff-Radford Neill; Estus Steve; Brookes Anthony J; Younkin Steven G
Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.
Human molecular genetics 2005;14(3):447-60.
2005: Lovell Mark A; Xiong Shuling; Markesbery William R; Lynn Bert C
Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide.
Neurochemical research 2005;30(1):113-22.
2005: Montine Thomas J; Montine Kathleen S; McMahan Wendy; Markesbery William R; Quinn Joseph F; Morrow Jason D
F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
Antioxidants & redox signaling 2005;7(1-2):269-75.
2005: Petrovitch Helen; Ross G Webster; Steinhorn Sandra C; Abbott Robert D; Markesbery William; Davis Daron; Nelson James; Hardman John; Masaki Kamal; Vogt Margaret R; Launer Lenore; White Lon R
AD lesions and infarcts in demented and non-demented Japanese-American men.
Annals of neurology 2005;57(1):98-103.
2005: Lovell M A; Smith J L; Xiong S; Markesbery W R
Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.
Neurotoxicity research 2005;7(4):265-71.
2004: Lovell Mark A; Xiong Shuling; Xie Chengsong; Davies Peter; Markesbery William R
Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.
Journal of Alzheimer's disease : JAD 2004;6(6):659-71; discussion 673-81.
2004: Kashon Michael L; Ross G Webster; O'Callaghan James P; Miller Diane B; Petrovitch Helen; Burchfiel Cecil M; Sharp Dan S; Markesbery William R; Davis Daron G; Hardman John; Nelson James; White Lon R
Associations of cortical astrogliosis with cognitive performance and dementia status.
Journal of Alzheimer's disease : JAD 2004;6(6):595-604; discussion 673-81.
2004: Ding Qunxing; Dimayuga Edgardo; Markesbery William R; Keller Jeffrey N
Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures.
Journal of neurochemistry 2004;91(5):1211-8.
2004: Jorm A F; Masaki K H; Davis D G; Hardman J; Nelson J; Markesbery W R; Petrovitch H; Ross G W; White L R
Memory complaints in nondemented men predict future pathologic diagnosis of Alzheimer disease.
Neurology 2004;63(10):1960-1.
2004: Ross G Webster; Petrovitch Helen; Abbott Robert D; Nelson James; Markesbery William; Davis Daron; Hardman John; Launer Lenore; Masaki Kamal; Tanner Caroline M; White Lon R
Parkinsonian signs and substantia nigra neuron density in decendents elders without PD.
Annals of neurology 2004;56(4):532-9.
2004: Horstmann Sonja; Perry Arie; Reifenberger Guido; Giangaspero Felice; Huang Herve; Hara Akira; Masuoka Jun; Rainov Nikolai G; Bergmann Markus; Heppner Frank L; Brandner Sebastian; Chimelli Leila; Montagna Nádia; Jackson Thad; Davis Daron G; Markesbery William R; Ellison David W; Weller Roy O; Taddei Gian L; Conti Renato; Del Bigio Marc R; González-Cámpora Ricardo; Radhakrishnan V V; Söylemezoglu Figen; Uro-Coste Emmanuelle; Qian Jiang; Kleihues Paul; Ohgaki Hiroko
Genetic and expression profiles of cerebellar liponeurocytomas.
Brain pathology (Zurich, Switzerland) 2004;14(3):281-9.
2004: Ricciarelli Roberta; D'Abramo Cristina; Zingg Jean-Marc; Giliberto Luca; Markesbery William; Azzi Angelo; Marinari Umberto M; Pronzato Maria A; Tabaton Massimo
CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease.
Free radical biology & medicine 2004;36(8):1018-24.
2004: Drake Jennifer; Petroze Robin; Castegna Alessandra; Ding Qunxing; Keller Jeffrey N; Markesbery William R; Lovell Mark A; Butterfield D Allan
4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease.
Neuroscience letters 2004;356(3):155-8.
2004: Mortimer J A; Gosche K M; Riley K P; Markesbery W R; Snowdon D A
Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study.
Neurology 2004;62(3):428-32.
2004: Blalock Eric M; Geddes James W; Chen Kuey Chu; Porter Nada M; Markesbery William R; Landfield Philip W
Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(7):2173-8.
2004: Kryscio Richard J; Mendiondo Marta S; Schmitt Frederick A; Markesbery William R
Designing a large prevention trial: statistical issues.
Statistics in medicine 2004;23(2):285-96.
2003: Lovell Mark A; Xie Chengsong; Xiong Shuling; Markesbery William R
Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease.
Brain research 2003;983(1-2):84-96.
2003: Mortimer James A; Snowdon David A; Markesbery William R
Head circumference, education and risk of dementia: findings from the Nun Study.
Journal of clinical and experimental neuropsychology 2003;25(5):671-9.
2003: Lovell Mark A; Xie Chengsong; Xiong Shuling; Markesbery William R
Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid.
Journal of Alzheimer's disease : JAD 2003;5(3):229-39.
2003: Castegna Alessandra; Thongboonkerd Visith; Klein Jon B; Lynn Bert; Markesbery William R; Butterfield D Allan
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
Journal of neurochemistry 2003;85(6):1394-401.
2003: Ai Yi; Markesbery William; Zhang Zhiming; Grondin Richard; Elseberry Dennis; Gerhardt Greg A; Gash Don M
Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.
The Journal of comparative neurology 2003;461(2):250-61.
2003: Pulliam Joseph F; Jennings C Darrell; Kryscio Richard J; Davis Daron G; Wilson Dianne; Montine Thomas J; Schmitt Frederick A; Markesbery William R
Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;119B(1):48-53.
2003: Nath Avindra; Hall Elizabeth; Tuzova Marnia; Dobbs Michael; Jons Melina; Anderson Caroline; Woodward Jerold; Guo Zhihong; Fu Weiming; Kryscio Richard; Wekstein David; Smith Charles; Markesbery William R; Mattson Mark P
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development.
Neuromolecular medicine 2003;3(1):29-39.
2002: White Lon; Petrovitch Helen; Hardman John; Nelson James; Davis Daron G; Ross G Webster; Masaki Kamal; Launer Lenore; Markesbery William R
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.
Annals of the New York Academy of Sciences 2002;977():9-23.
2002: Castegna Alessandra; Aksenov Michael; Thongboonkerd Visith; Klein Jon B; Pierce William M; Booze Rosemarie; Markesbery William R; Butterfield D Allan
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.
Journal of neurochemistry 2002;82(6):1524-32.
2002: Montine Thomas J; Neely M Diana; Quinn Joseph F; Beal M Flint; Markesbery William R; Roberts L Jackson; Morrow Jason D
Lipid peroxidation in aging brain and Alzheimer's disease.
Free radical biology & medicine 2002;33(5):620-6.
2002: Castegna Alessandra; Aksenov Michael; Aksenova Marina; Thongboonkerd Visith; Klein Jon B; Pierce William M; Booze Rosemarie; Markesbery William R; Butterfield D Allan
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
Free radical biology & medicine 2002;33(4):562-71.
2002: Riley Kathryn P; Snowdon David A; Markesbery William R
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.
Annals of neurology 2002;51(5):567-77.
2002: Gosche K M; Mortimer J A; Smith C D; Markesbery W R; Snowdon D A
Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.
Neurology 2002;58(10):1476-82.
2002: Williamson Kelly S; Gabbita S Prasad; Mou Shenyun; West Melinda; Pye Quentin N; Markesbery William R; Cooney Robert V; Grammas Paula; Reimann-Philipp Ulrich; Floyd Robert A; Hensley Kenneth
The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2002;6(2):221-7.
2002: Lovell Mark A; Robertson J David; Buchholz Bruce A; Xie Chengsong; Markesbery William R
Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer's disease.
Neurobiology of aging 2002;23(2):179-86.
2002: Bassett Casey N; Swift Larry L; Montine Kathleen S; Markesbery William R; Montine Thomas J
Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
Journal of Alzheimer's disease : JAD 2002;4(1):19-30.
2001: Ko L W; Sheu K F; Thaler H T; Markesbery W R; Blass J P
Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability?
Journal of molecular neuroscience : MN 2001;17(3):361-9.
2001: Schmitt F A; Wetherby M M; Wekstein D R; Dearth C M; Markesbery W R
Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project.
The Gerontologist 2001;41(6):716-22.
2001: Gosche K M; Mortimer J A; Smith C D; Markesbery W R; Snowdon D A
An automated technique for measuring hippocampal volumes from MR imaging studies.
AJNR. American journal of neuroradiology 2001;22(9):1686-9.
2001: Picklo M J; Olson S J; Hayes J D; Markesbery W R; Montine T J
Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease.
Brain research 2001;916(1-2):229-38.
2001: Petrovitch H; White L R; Ross G W; Steinhorn S C; Li C Y; Masaki K H; Davis D G; Nelson J; Hardman J; Curb J D; Blanchette P L; Launer L J; Yano K; Markesbery W R
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study.
Neurology 2001;57(2):226-34.
2001: Lauderback C M; Hackett J M; Huang F F; Keller J N; Szweda L I; Markesbery W R; Butterfield D A
The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.
Journal of neurochemistry 2001;78(2):413-6.
2001: Picklo M J; Olson S J; Markesbery W R; Montine T J
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease.
Journal of neuropathology and experimental neurology 2001;60(7):686-95.
2001: Xie C; Lovell M A; Xiong S; Kindy M S; Guo J; Xie J; Amaranth V; Montine T J; Markesbery W R
Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress.
Free radical biology & medicine 2001;31(1):73-81.
2001: Wackerbarth S B; Johnson M M; Markesbery W R; Smith C D
Urban-rural differences in a memory disorders clinical population.
Journal of the American Geriatrics Society 2001;49(5):647-50.
2001: Aksenov M Y; Markesbery W R
Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease.
Neuroscience letters 2001;302(2-3):141-5.
2001: Lovell M A; Markesbery W R
Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid.
Archives of neurology 2001;58(3):392-6.
2001: Lovell M A; Xie C; Markesbery W R
Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.
Neurobiology of aging 2001;22(2):187-94.
2001: Lauderback C M; Hackett J M; Keller J N; Varadarajan S; Szweda L; Kindy M; Markesbery W R; Butterfield D A
Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.
Biochemistry 2001;40(8):2548-54.
2001: Reich E E; Markesbery W R; Roberts L J; Swift L L; Morrow J D; Montine T J
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease.
The American journal of pathology 2001;158(1):293-7.
2001: Reich E E; Markesbery W R; Roberts L J; Swift L L; Morrow J D; Montine T J
Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease.
Advances in experimental medicine and biology 2001;500():253-6.
2001: Aksenov M Y; Aksenova M V; Butterfield D A; Geddes J W; Markesbery W R
Protein oxidation in the brain in Alzheimer's disease.
Neuroscience 2001;103(2):373-83.
2000: Lovell M A; Xie C; Markesbery W R
Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures.
Free radical biology & medicine 2000;29(8):714-20.
2000: Schmitt F A; Davis D G; Wekstein D R; Smith C D; Ashford J W; Markesbery W R
"Preclinical" AD revisited: neuropathology of cognitively normal older adults.
Neurology 2000;55(3):370-6.
2000: Keller J N; Markesbery W R
Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death.
Journal of neuroscience research 2000;61(4):436-42.
2000: Keller J N; Hanni K B; Markesbery W R
Impaired proteasome function in Alzheimer's disease.
Journal of neurochemistry 2000;75(1):436-9.
2000: Aksenov M; Aksenova M; Butterfield D A; Markesbery W R
Oxidative modification of creatine kinase BB in Alzheimer's disease brain.
Journal of neurochemistry 2000;74(6):2520-7.
2000: Snowdon D A; Greiner L H; Markesbery W R
Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study.
Annals of the New York Academy of Sciences 2000;903():34-8.
2000: White L R; Petrovitch H; Ross G W; Masaki K; Hardman J; Nelson J; Davis D; Markesbery W
Brain aging and midlife tofu consumption.
Journal of the American College of Nutrition 2000;19(2):242-55.
2000: Keller J N; Lauderback C M; Butterfield D A; Kindy M S; Yu J; Markesbery W R
Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice.
Journal of neurochemistry 2000;74(4):1579-86.
2000: Snowdon D A; Tully C L; Smith C D; Riley K P; Markesbery W R
Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study.
The American journal of clinical nutrition 2000;71(4):993-8.
2000: Xie C; Markesbery W R; Lovell M A
Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium.
Free radical biology & medicine 2000;28(5):665-72.
2000: Lovell M A; Xie C; Gabbita S P; Markesbery W R
Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain.
Free radical biology & medicine 2000;28(3):418-27.
2000: Smith C D; Snowdon D A; Wang H; Markesbery W R
White matter volumes and periventricular white matter hyperintensities in aging and dementia.
Neurology 2000;54(4):838-42.
2000: Lovell M A; Xie C; Markesbery W R
Decreased base excision repair and increased helicase activity in Alzheimer's disease brain.
Brain research 2000;855(1):116-23.
2000: Petrovitch H; White L R; Izmirilian G; Ross G W; Havlik R J; Markesbery W; Nelson J; Davis D G; Hardman J; Foley D J; Launer L J
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study.
Neurobiology of aging 2000;21(1):57-62.
2000: Keller J N; Hanni K B; Markesbery W R
Possible involvement of proteasome inhibition in aging: implications for oxidative stress.
Mechanisms of ageing and development 2000;113(1):61-70.
2000: Smith C D; Snowdon D; Markesbery W R
Periventricular white matter hyperintensities on MRI: correlation with neuropathologic findings.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2000;10(1):13-6.
2000: Keller J N; Huang F F; Markesbery W R
Decreased levels of proteasome activity and proteasome expression in aging spinal cord.
Neuroscience 2000;98(1):149-56.
1999: Bassett C N; Neely M D; Sidell K R; Markesbery W R; Swift L L; Montine T J
Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.
Lipids 1999;34(12):1273-80.
1999: Arnold S M; Young A B; Munn R K; Patchell R A; Nanayakkara N; Markesbery W R
Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4028-33.
1999: Markesbery W R
The role of oxidative stress in Alzheimer disease.
Archives of neurology 1999;56(12):1449-52.
1999: Keller J N; Hanni K B; Markesbery W R
4-hydroxynonenal increases neuronal susceptibility to oxidative stress.
Journal of neuroscience research 1999;58(6):823-30.
1999: Wolf D S; Gearing M; Snowdon D A; Mori H; Markesbery W R; Mirra S S
Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study.
Alzheimer disease and associated disorders 1999;13(4):226-31.
1999: Montine T J; Sidell K R; Crews B C; Markesbery W R; Marnett L J; Roberts L J; Morrow J D
Elevated CSF prostaglandin E2 levels in patients with probable AD.
Neurology 1999;53(7):1495-8.
1999: Smith C D; Umberger G H; Manning E L; Slevin J T; Wekstein D R; Schmitt F A; Markesbery W R; Zhang Z; Gerhardt G A; Kryscio R J; Gash D M
Critical decline in fine motor hand movements in human aging.
Neurology 1999;53(7):1458-61.
1999: Aksenova M V; Aksenov M Y; Markesbery W R; Butterfield D A
Aging in a dish: age-dependent changes of neuronal survival, protein oxidation, and creatine kinase BB expression in long-term hippocampal cell culture.
Journal of neuroscience research 1999;58(2):308-17.
1999: Gabbita S P; Aksenov M Y; Lovell M A; Markesbery W R
Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain.
Journal of neurochemistry 1999;73(4):1660-6.
1999: Montine T J; Markesbery W R; Zackert W; Sanchez S C; Roberts L J; Morrow J D
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
The American journal of pathology 1999;155(3):863-8.
1999: Aksenov M Y; Tucker H M; Nair P; Aksenova M V; Butterfield D A; Estus S; Markesbery W R
The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.
Neurochemical research 1999;24(6):767-74.
1999: Keller J N; Hanni K B; Markesbery W R
Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases.
Journal of neurochemistry 1999;72(6):2601-9.
1999: Keller J N; Hanni K B; Pedersen W A; Cashman N R; Mattson M P; Gabbita S P; Friebe V; Markesbery W R
Opposing actions of native and oxidized lipoprotein on motor neuron-like cells.
Experimental neurology 1999;157(1):202-10.
1999: Hensley K; Floyd R A; Zheng N Y; Nael R; Robinson K A; Nguyen X; Pye Q N; Stewart C A; Geddes J; Markesbery W R; Patel E; Johnson G V; Bing G
p38 kinase is activated in the Alzheimer's disease brain.
Journal of neurochemistry 1999;72(5):2053-8.
1999: Lanska D J; Markesbery W R
CADASIL in a North American family.
Neurology 1999;52(7):1518-9.
1999: Davis D G; Schmitt F A; Wekstein D R; Markesbery W R
Alzheimer neuropathologic alterations in aged cognitively normal subjects.
Journal of neuropathology and experimental neurology 1999;58(4):376-88.
1999: Goedert M; Spillantini M G; Crowther R A; Chen S G; Parchi P; Tabaton M; Lanska D J; Markesbery W R; Wilhelmsen K C; Dickson D W; Petersen R B; Gambetti P
Tau gene mutation in familial progressive subcortical gliosis.
Nature medicine 1999;5(4):454-7.
1999: Lovell M A; Xie C; Markesbery W R
Protection against amyloid beta peptide toxicity by zinc.
Brain research 1999;823(1-2):88-95.
1999: Aksenova M V; Aksenov M Y; Payne R M; Trojanowski J Q; Schmidt M L; Carney J M; Butterfield D A; Markesbery W R
Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders.
Dementia and geriatric cognitive disorders 1999;10(2):158-65.
1999: Saxe S R; Wekstein M W; Kryscio R J; Henry R G; Cornett C R; Snowdon D A; Grant F T; Schmitt F A; Donegan S J; Wekstein D R; Ehmann W D; Markesbery W R
Alzheimer's disease, dental amalgam and mercury.
Journal of the American Dental Association (1939) 1999;130(2):191-9.
1999: Lovell M A; Gabbita S P; Markesbery W R
Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.
Journal of neurochemistry 1999;72(2):771-6.
1999: Markesbery W R; Carney J M
Oxidative alterations in Alzheimer's disease.
Brain pathology (Zurich, Switzerland) 1999;9(1):133-46.
1999: Smith C D; Malcein M; Meurer K; Schmitt F A; Markesbery W R; Pettigrew L C
MRI temporal lobe volume measures and neuropsychologic function in Alzheimer's disease.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 1999;9(1):2-9.
1998: Yatin S M; Aksenova M; Aksenov M; Markesbery W R; Aulick T; Butterfield D A
Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.
Journal of molecular neuroscience : MN 1998;11(3):183-97.
1998: Lovell M A; Xie C; Markesbery W R
Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.
Neurology 1998;51(6):1562-6.
1998: Montine K S; Bassett C N; Ou J J; Markesbery W R; Swift L L; Montine T J
Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins.
Journal of lipid research 1998;39(12):2443-51.
1998: Keller J N; Hanni K B; Mattson M P; Markesbery W R
Cyclic nucleotides attenuate lipid peroxidation-mediated neuron toxicity.
Neuroreport 1998;9(16):3731-4.
1998: Xie C; Lovell M A; Markesbery W R
Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity.
Free radical biology & medicine 1998;25(8):979-88.
1998: Pedersen W A; Fu W; Keller J N; Markesbery W R; Appel S; Smith R G; Kasarskis E; Mattson M P
Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients.
Annals of neurology 1998;44(5):819-24.
1998: Patchell R A; Tibbs P A; Regine W F; Dempsey R J; Mohiuddin M; Kryscio R J; Markesbery W R; Foon K A; Young B
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
JAMA : the journal of the American Medical Association 1998;280(17):1485-9.
1998: Zhang D; Dhillon H; Prasad M R; Markesbery W R
Regional levels of brain phospholipase Cgamma in Alzheimer's disease.
Brain research 1998;811(1-2):161-5.
1998: Gabbita S P; Lovell M A; Markesbery W R
Increased nuclear DNA oxidation in the brain in Alzheimer's disease.
Journal of neurochemistry 1998;71(5):2034-40.
1998: Aksenov M Y; Tucker H M; Nair P; Aksenova M V; Butterfield D A; Estus S; Markesbery W R
The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.
Journal of molecular neuroscience : MN 1998;11(2):151-64.
1998: Hensley K; Maidt M L; Yu Z; Sang H; Markesbery W R; Floyd R A
Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(20):8126-32.
1998: Montine T J; Markesbery W R; Morrow J D; Roberts L J
Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
Annals of neurology 1998;44(3):410-3.
1998: Aksenov M Y; Aksenova M V; Markesbery W R; Butterfield D A
Amyloid beta-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons. Protein carbonyl formation, CK BB expression, and the level of Cu, Zn, and Mn SOD mRNA.
Journal of molecular neuroscience : MN 1998;10(3):181-92.
1998: Lovell M A; Robertson J D; Teesdale W J; Campbell J L; Markesbery W R
Copper, iron and zinc in Alzheimer's disease senile plaques.
Journal of the neurological sciences 1998;158(1):47-52.
1998: Cornett C R; Markesbery W R; Ehmann W D
Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain.
Neurotoxicology 1998;19(3):339-45.
1998: Lanska D J; Markesbery W R; Cochran E; Bennett D; Lanska M J; Cohen M
Late-onset sporadic progressive subcortical gliosis.
Journal of the neurological sciences 1998;157(2):143-7.
1998: Montine K S; Reich E; Neely M D; Sidell K R; Olson S J; Markesbery W R; Montine T J
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.
Journal of neuropathology and experimental neurology 1998;57(5):415-25.
1998: Roberts L J; Montine T J; Markesbery W R; Tapper A R; Hardy P; Chemtob S; Dettbarn W D; Morrow J D
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.
The Journal of biological chemistry 1998;273(22):13605-12.
1998: Cornett C R; Ehmann W D; Wekstein D R; Markesbery W R
Trace elements in Alzheimer's disease pituitary glands.
Biological trace element research 1998;62(1-2):107-14.
1998: Bruce-Keller A J; Li Y J; Lovell M A; Kraemer P J; Gary D S; Brown R R; Markesbery W R; Mattson M P
4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats.
Journal of neuropathology and experimental neurology 1998;57(3):257-67.
1998: Pettigrew L C; Bieber F; Lettieri J; Wermeling D P; Schmitt F A; Tikhtman A J; Ashford J W; Smith C D; Wekstein D R; Markesbery W R; Orazem J; Ruzicka B B; Mas J; Gulanski B
Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease.
Journal of clinical pharmacology 1998;38(3):236-45.
1998: Challa V R; Lovell M A; Moody D M; Brown W R; Reboussin D M; Markesbery W R
Laser microprobe mass spectrometric study of aluminum and silicon in brain emboli related to cardiac surgery.
Journal of neuropathology and experimental neurology 1998;57(2):140-7.
1998: Tekirian T L; Saido T C; Markesbery W R; Russell M J; Wekstein D R; Patel E; Geddes J W
N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits.
Journal of neuropathology and experimental neurology 1998;57(1):76-94.
1998: Markesbery W R; Lovell M A
Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.
Neurobiology of aging 1998;19(1):33-6.
1998: Prasad M R; Lovell M A; Yatin M; Dhillon H; Markesbery W R
Regional membrane phospholipid alterations in Alzheimer's disease.
Neurochemical research 1998;23(1):81-8.
1997: Lovell M A; Ehmann W D; Mattson M P; Markesbery W R
Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.
Neurobiology of aging 1997;18(5):457-61.
1997: Aksenov M Y; Aksenova M V; Payne R M; Smith C D; Markesbery W R; Carney J M
The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease.
Experimental neurology 1997;146(2):458-65.
1997: Montine K S; Kim P J; Olson S J; Markesbery W R; Montine T J
4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease.
Journal of neuropathology and experimental neurology 1997;56(8):866-71.
1997: Geddes J W; Tekirian T L; Soultanian N S; Ashford J W; Davis D G; Markesbery W R
Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease.
Neurobiology of aging 1997;18(4 Suppl):S99-105.
1997: Markesbery W R
Neuropathological criteria for the diagnosis of Alzheimer's disease.
Neurobiology of aging 1997;18(4 Suppl):S13-9.
1997: Snowdon D A; Greiner L H; Mortimer J A; Riley K P; Greiner P A; Markesbery W R
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
JAMA : the journal of the American Medical Association 1997;277(10):813-7.
1997: Mark R J; Lovell M A; Markesbery W R; Uchida K; Mattson M P
A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide.
Journal of neurochemistry 1997;68(1):255-64.
1997: Markesbery W R
Oxidative stress hypothesis in Alzheimer's disease.
Free radical biology & medicine 1997;23(1):134-47.
1996: Deibel M A; Ehmann W D; Markesbery W R
Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.
Journal of the neurological sciences 1996;143(1-2):137-42.
1996: Lovell M A; Ehmann W D; Markesbery W R; Melethil S; Swyt C R; Zatta P F
Standardization in biological analyses of aluminum: what are the needs?
Journal of toxicology and environmental health 1996;48(6):637-48.
1996: Hensley K; Butterfield D A; Hall N; Cole P; Subramaniam R; Mark R; Mattson M P; Markesbery W R; Harris M E; Aksenov M
Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide.
Annals of the New York Academy of Sciences 1996;786():120-34.
1996: Tekirian T L; Cole G M; Russell M J; Yang F; Wekstein D R; Patel E; Snowdon D A; Markesbery W R; Geddes J W
Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains.
Neurobiology of aging 1996;17(2):249-57.
1996: Snowdon D A; Kemper S J; Mortimer J A; Greiner L H; Wekstein D R; Markesbery W R
Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study.
JAMA : the journal of the American Medical Association 1996;275(7):528-32.
1995: Markesbery W R; Ehmann W D; Candy J M; Ince P G; Shaw P J; Tandon L; Deibel M A
Neutron activation analysis of trace elements in motor neuron disease spinal cord.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(4):383-90.
1995: Tully C L; Snowdon D A; Markesbery W R
Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study.
Neuroreport 1995;6(16):2105-8.
1995: Mattson M P; Lovell M A; Furukawa K; Markesbery W R
Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons.
Journal of neurochemistry 1995;65(4):1740-51.
1995: Lovell M A; Ehmann W D; Butler S M; Markesbery W R
Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.
Neurology 1995;45(8):1594-601.
1995: Samudralwar D L; Diprete C C; Ni B F; Ehmann W D; Markesbery W R
Elemental imbalances in the olfactory pathway in Alzheimer's disease.
Journal of the neurological sciences 1995;130(2):139-45.
1995: Petersen R B; Tabaton M; Chen S G; Monari L; Richardson S L; Lynch T; Manetto V; Lanska D J; Markesbery W R; Lynches T [corrected to Lynch T ]
Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17.
Neurology 1995;45(6):1062-7.
1994: Ince P G; Shaw P J; Candy J M; Mantle D; Tandon L; Ehmann W D; Markesbery W R
Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease.
Neuroscience letters 1994;182(1):87-90.
1994: Lanska D J; Currier R D; Cohen M; Gambetti P; Smith E E; Bebin J; Jackson J F; Whitehouse P J; Markesbery W R
Familial progressive subcortical gliosis.
Neurology 1994;44(9):1633-43.
1994: Kittur S; Hoh J; Endo H; Tourtellotte W; Weeks B S; Markesbery W; Adler W
Cytoskeletal neurofilament gene expression in brain tissue from Alzheimer's disease patients. I. Decrease in NF-L and NF-M message.
Journal of geriatric psychiatry and neurology 1994;7(3):153-8.
1994: Blass J P; Markesbery W R; Ko L W; DeGiorgio L; Sheu K F; Darzynkiewicz Z
Presence of neuronal proteins in serially cultured cells from autopsy human brain.
Journal of the neurological sciences 1994;121(2):132-8.
1994: Xie X; Yokel R A; Markesbery W R
Application of electron energy loss spectroscopy and electron spectroscopic imaging to aluminum determination in biological tissue.
Biological trace element research 1994;40(1):39-48.
1993: Hamill R W; Markesbery W R; McDaniel K; Coleman P D
Characterization of brain samples in studies of aging, Alzheimer's, and other neurodegenerative diseases.
Neurobiology of aging 1993;14(6):539-45.
1993: Carpenter A F; Carpenter P W; Markesbery W R
Morphometric analysis of microglia in Alzheimer's disease.
Journal of neuropathology and experimental neurology 1993;52(6):601-8.
1993: Davis D G; Wilson D; Schmitz M; Markesbery W R
Lipidized medulloblastoma in adults.
Human pathology 1993;24(9):990-5.
1993: Markesbery W R; Wang H Z; Kowall N W; Kosik K S; McKee A C
Morphometric image analysis of neuropil threads in Alzheimer's disease.
Neurobiology of aging 1993;14(4):303-7.
1993: Markesbery W R
The diagnosis of Alzheimer's disease.
Archives of pathology & laboratory medicine 1993;117(2):129-31.
1993: Smith C D; Gallenstein L G; Layton W J; Kryscio R J; Markesbery W R
31P magnetic resonance spectroscopy in Alzheimer's and Pick's disease.
Neurobiology of aging 1993;14(1):85-92.
1993: Mattson M P; Lovell M A; Ehmann W D; Markesbery W R
Comparison of the effects of elevated intracellular aluminum and calcium levels on neuronal survival and tau immunoreactivity.
Brain research 1993;602(1):21-31.
1993: Lovell M A; Ehmann W D; Markesbery W R
Laser microprobe analysis of brain aluminum in Alzheimer's disease.
Annals of neurology 1993;33(1):36-42.
1993: Kasarskis E J; Ehmann W D; Markesbery W R
Trace metals in human neurodegenerative diseases.
Progress in clinical and biological research 1993;380():299-310.
1992: Russell M J; White R; Patel E; Markesbery W R; Watson C R; Geddes J W
Familial influence on plaque formation in the beagle brain.
Neuroreport 1992;3(12):1093-6.
1992: Smith C D; Carney J M; Tatsumo T; Stadtman E R; Floyd R A; Markesbery W R
Protein oxidation in aging brain.
Annals of the New York Academy of Sciences 1992;663():110-9.
1992: DeKosky S T; Harbaugh R E; Schmitt F A; Bakay R A; Chui H C; Knopman D S; Reeder T M; Shetter A G; Senter H J; Markesbery W R
Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group.
Annals of neurology 1992;32(5):625-32.
1992: Davis D G; Wang H Z; Markesbery W R
Image analysis of neuropil threads in Alzheimer's, Pick's, diffuse Lewy body disease and in progressive supranuclear palsy.
Journal of neuropathology and experimental neurology 1992;51(6):594-600.
1992: Sparks D L; Hunsaker J C; Slevin J T; DeKosky S T; Kryscio R J; Markesbery W R
Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Annals of neurology 1992;31(6):611-20.
1992: Davis D G; Markesbery W R
Perivascular siderophages in skeletal muscle from a patient with diabetic neuropathy.
Acta neuropathologica 1992;84(2):216-20.
1992: Kittur S D; Endo H; Adler W H; Martin G R; Markesbery W R; Kleinman H K; Weeks B S
Alzheimer disease brain extract stimulates branching of laminin-mediated neuronal processes.
Alzheimer disease and associated disorders 1992;6(2):103-10.
1992: Xu N; Majidi V; Markesbery W R; Ehmann W D
Brain aluminum in Alzheimer's disease using an improved GFAAS method.
Neurotoxicology 1992;13(4):735-43.
1991: Smith C D; Carney J M; Starke-Reed P E; Oliver C N; Stadtman E R; Floyd R A; Markesbery W R
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10540-3.
1991: Sparks D L; Markesbery W R
Altered serotonergic and cholinergic synaptic markers in Pick's disease.
Archives of neurology 1991;48(8):796-9.
1991: Sparks D L; Woeltz V M; Markesbery W R
Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease.
Archives of neurology 1991;48(7):718-21.
1991: Markesbery W R
Comments on vascular dementia.
Alzheimer disease and associated disorders 1991;5(2):149-53.
1990: Smith C D; Thomas G S; Kryscio R J; Markesbery W R
31P spectroscopy in experimental embolic stroke: correlation with infarct size.
NMR in biomedicine 1990;3(6):259-64.
1990: Wenstrup D; Ehmann W D; Markesbery W R
Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains.
Brain research 1990;533(1):125-31.
1990: Sparks D L; Hunsaker J C; Scheff S W; Kryscio R J; Henson J L; Markesbery W R
Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease.
Neurobiology of aging 1990;11(6):601-7.
1990: Cross R J; Campbell J L; Markesbery W R; Roszman T L
Transplantation of pituitary grafts fail to restore immune function and to reconstitute the thymus glands of aged mice.
Mechanisms of ageing and development 1990;56(1):11-22.
1990: Davis D G; Nelson K R; Markesbery W R
Congenital myopathy and cardiomyopathy with identical ultrastructural changes.
Archives of neurology 1990;47(10):1141-4.
1990: Vance D E; Ehmann W D; Markesbery W R
A search for longitudinal variations in trace element levels in nails of Alzheimer's disease patients.
Biological trace element research 1990;26-27():461-70.
1990: Patchell R A; Tibbs P A; Walsh J W; Dempsey R J; Maruyama Y; Kryscio R J; Markesbery W R; Macdonald J S; Young B
A randomized trial of surgery in the treatment of single metastases to the brain.
The New England journal of medicine 1990;322(8):494-500.
1990: Khare S S; Ehmann W D; Kasarskis E J; Markesbery W R
Trace element imbalances in amyotrophic lateral sclerosis.
Neurotoxicology 1990;11(3):521-32.
1989: Markesbery W R
Alzheimer's disease--a mini review.
The Journal of the Kentucky Medical Association 1989;87(7):333-5.
1989: Doebler J A; Rhoads R E; Anthony A; Markesbery W R
Neuronal RNA in Pick's and Alzheimer's diseases. Comparison of disease-susceptible and disease-resistant cortical areas.
Archives of neurology 1989;46(2):134-7.
1988: Sparks D L; DeKosky S T; Markesbery W R
Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus.
Archives of neurology 1988;45(9):994-9.
1988: Vance D E; Ehmann W D; Markesbery W R
Trace element content in fingernails and hair of a nonindustrialized US control population.
Biological trace element research 1988;17():109-21.
1988: Davis D; Henslee P J; Markesbery W R
Fatal adenovirus meningoencephalitis in a bone marrow transplant patient.
Annals of neurology 1988;23(4):385-9.
1988: Doebler J A; Markesbery W R; Anthony A; Davies P; Scheff S W; Rhoads R E
Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease.
Annals of neurology 1988;23(1):20-4.
1988: Thompson C M; Markesbery W R; Ehmann W D; Mao Y X; Vance D E
Regional brain trace-element studies in Alzheimer's disease.
Neurotoxicology 1988;9(1):1-7.
1988: Vance D E; Ehmann W D; Markesbery W R
Trace element imbalances in hair and nails of Alzheimer's disease patients.
Neurotoxicology 1988;9(2):197-208.
1988: Doebler J A; Markesbery W R; Anthony A; Scheff S W; Rhoads R E
Astrocyte RNA in relation to neuronal RNA depletion in Alzheimer's disease.
Acta neuropathologica 1988;75(3):272-6.
1987: Shih W J; Markesbery W R; Clark D B; Goldstein S; Domstad P A; Coupal J J; Kung H; DeKosky S T; DeLand F H
Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(9):1484-7.
1987: Doebler J A; Markesbery W R; Anthony A; Rhoads R E
In situ analysis of neostriatal RNA and chromatin in Alzheimer's disease.
Neurology 1987;37(2):309-13.
1987: Doebler J A; Markesbery W R; Anthony A; Rhoads R E
Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease.
Journal of neuropathology and experimental neurology 1987;46(1):28-39.
1986: Walsh J W; Zimmer S G; Oeltgen J; Markesbery W R
Invasiveness in primary intracranial tumors: Part 1. An experimental model using cloned SV40 virus-produced hamster brain tumors.
Neurosurgery 1986;19(2):185-200.
1986: Chin H W; Maruyama Y; Young B; Markesbery W; Tibbs P; Goldstein S
A clinical study with brain brachytherapy for malignant gliomas.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1986;162(7):433-6.
1986: Sparks D L; Markesbery W R; Slevin J T
Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
Annals of neurology 1986;19(6):602-4.
1986: Cross R J; Jackson J C; Brooks W H; Sparks D L; Markesbery W R; Roszman T L
Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment.
Immunology 1986;57(1):145-52.
1986: Ehmann W D; Markesbery W R; Alauddin M; Hossain T I; Brubaker E H
Brain trace elements in Alzheimer's disease.
Neurotoxicology 1986;7(1):195-206.
1985: DeKosky S T; Scheff S W; Markesbery W R
Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.
Neurology 1985;35(10):1425-31.
1985: Goldstein S J; Wekstein D R; Kirkpatrick C; Lee C; Markesbery W R
Imaging the centenarian brain. A computed tomographic study.
Journal of the American Geriatrics Society 1985;33(9):579-84.
1985: Roszman T L; Jackson J C; Cross R J; Titus M J; Markesbery W R; Brooks W H
Neuroanatomic and neurotransmitter influences on immune function.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2 Suppl):769s-772s.
1985: Butterfield D A; Nicholas M M; Markesbery W R
Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease.
Neurochemical research 1985;10(7):909-18.
1985: Butterfield D A; Farmer B T; Markesbery W R
Alzheimer's disease: no alteration in the physical state of erythrocyte membrane glycoconjugates.
Annals of neurology 1985;18(1):104-5.
1985: Baumann R J; Walsh J W; Gilmore R L; Lee C; Wong P; Wilson H D; Markesbery W R
Brain biopsy in cases of neonatal herpes simplex encephalitis.
Neurosurgery 1985;16(5):619-24.
1985: Jackson J C; Cross R J; Walker R F; Markesbery W R; Brooks W H; Roszman T L
Influence of serotonin on the immune response.
Immunology 1985;54(3):505-12.
1985: Sparks D L; Markesbery W R; Slevin J T
Age-associated alteration of serotonergic synaptic neurochemistry in rat rostral hypothalamus.
Neurobiology of aging 1985;6(3):213-7.
1984: Peretz B; Romanenko A; Markesbery W
Functional history of two motor neurons and the morphometry of their neuromuscular junctions in the gill of Aplysia: evidence for differential aging.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(13):4232-6.
1984: Cross R J; Jackson J C; Roszman T L; Brooks W H; Markesbery W R
Role of spontaneous interstitial cell testicular tumors on the mitogen reactivity of spleen cells from aged male Fischer-344 rats.
Mechanisms of ageing and development 1984;25(3):349-53.
1984: Cross R J; Markesbery W R; Brooks W H; Roszman T L
Hypothalamic-immune interactions: neuromodulation of natural killer activity by lesioning of the anterior hypothalamus.
Immunology 1984;51(2):399-405.
1984: Ehmann W D; Alauddin M; Hossain T I; Markesbery W R
Brain trace elements in Pick's disease.
Annals of neurology 1984;15(1):102-4.
1984: Markesbery W R; Ehmann W D; Alauddin M; Hossain T I
Brain trace element concentrations in aging.
Neurobiology of aging 1984;5(1):19-28.
1984: Markesbery W R; Ehmann W D; Hossain T I; Alauddin M
Brain manganese concentrations in human aging and Alzheimer's disease.
Neurotoxicology 1984;5(1):49-57.
1984: Cross R J; Brooks W H; Roszman T L; Markesbery W R
Neuromodulation of lymphocyte reactivity in aged rats.
Neurobiology of aging 1984;5(2):89-92.
1984: Maruyama Y; Chin H W; Young A B; Beach J; Tibbs P; Goldstein S; Markesbery W
CT and MR for brain tumor implant therapy using CF-252 neutrons.
Journal of neuro-oncology 1984;2(4):349-60.
1984: Chin H W; Maruyama Y; Young B; Markesbery W; Goldstein S; Tibbs P; Beach L
Intracerebral neutron brachytherapy for hemispheric glioblastoma multiforme. A pilot study.
Journal of neuro-oncology 1984;2(4):341-7.
1984: Chin H W; Maruyama Y; Tibbs P; Markesbery W; Young B
Cerebellar glioblastoma in childhood.
Journal of neuro-oncology 1984;2(1):79-84.
1983: Haugh R M; Markesbery W R
Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function.
Archives of neurology 1983;40(9):560-3.
1983: Butterfield D A; Markesbery W R
Spin labeling studies of membrane proteins in erythrocyte ghosts from patients with Huntington's disease.
Neuroscience letters 1983;35(2):221-6.
1982: Baumann R J; Markesbery W R
Santavuori disease: diagnosis by leukocyte ultrastructure.
Neurology 1982;32(11):1277-81.
1982: Butterfield D A; Markesbery W R
Time-dependence of, and effects of inhibition and cellular aging on, chloride efflux across erythrocyte membranes in Huntington's disease.
Journal of the neurological sciences 1982;57(1):29-39.
1982: Walsh J W; Zimmer S G; Oeltgen J; Mason R; Perdue M L; Markesbery W R
SV-40 virus-induced neoplastic transformation of hamster brain cells in vitro. Studies with scanning and transmission electron microscopy.
Journal of neuropathology and experimental neurology 1982;41(6):588-605.
1982: Butterfield D A; Ordaz F E; Markesbery W R
Spin label studies of human erythrocyte membranes in aging.
Journal of gerontology 1982;37(5):535-9.
1982: Brooks W H; Cross R J; Roszman T L; Markesbery W R
Neuroimmunomodulation: neural anatomical basis for impairment and facilitation.
Annals of neurology 1982;12(1):56-61.
1982: Baker R S; Millett A J; Young A B; Markesbery W R
Effects of chronic denervation on the histology of canine extraocular muscle.
Investigative ophthalmology & visual science 1982;22(6):701-5.
1982: Chin H W; Maruyama Y; Markesbery W; Young A B
Intracranial ependymoma: results of radiotherapy at the University of Kentucky.
Cancer 1982;49(11):2276-80.
1982: Roszman T L; Cross R J; Brooks W H; Markesbery W R
Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis.
Immunology 1982;45(4):737-42.
1982: Cross R J; Brooks W H; Roszman T L; Markesbery W R
Hypothalamic-immune interactions. Effect of hypophysectomy on neuroimmunomodulation.
Journal of the neurological sciences 1982;53(3):557-66.
1981: Markesbery W R; Ehmann W D; Hossain T I; Alauddin M; Goodin D T
Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.
Annals of neurology 1981;10(6):511-6.
1981: Young B; Oldfield E H; Markesbery W R; Haack D; Tibbs P A; McCombs P; Chin H W; Maruyama Y; Meacham W F
Reoperation for glioblastoma.
Journal of neurosurgery 1981;55(6):917-21.
1981: Roszman T L; Brooks W H; Markesbery W R; Aziz G J; Bigner D D
Lymphocyte subpopulations and responsiveness in rats bearing intracranial tumors induced by avian sarcoma virus.
Journal of neurosurgery 1981;55(4):554-9.
1981: Butterfield D A; Markesbery W R
Huntington's disease: a generalized membrane defect.
Life sciences 1981;28(10):1117-31.
1981: Markesbery W R; Haugh R M; Young A B
Ultrastructure of pineal parenchymal neoplasms.
Acta neuropathologica 1981;55(2):143-9.
1980: Robertson W C; Clark D B; Markesbery W R
Review of 38 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease.
Annals of neurology 1980;8(4):422-5.
1980: Markesbery W R; Robinson R O; Falace P V; Frye M D
Mucopolysaccharidoses: ultrastructure of leukocyte inclusions.
Annals of neurology 1980;8(3):332-6.
1980: Cross R J; Markesbery W R; Brooks W H; Roszman T L
Hypothalamic-immune interactions. I. The acute effect of anterior hypothalamic lesions on the immune response.
Brain research 1980;196(1):79-87.
1980: Bialas W A; Markesbery W R; Butterfield D A
Increased chloride transport in erythrocytes in Huntington's disease.
Biochemical and biophysical research communications 1980;95(4):1895-900.
1980: Butterfield D A; Doorley P F; Markesbery W R
Evidence for a membrane surface defect in erythrocytes in Huntington's disease.
Life sciences 1980;27(7):609-15.
1980: Butterfield D A; Markesbery W R
Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological disorders--Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and duchenne muscular dystrophy.
Journal of the neurological sciences 1980;47(2):261-71.
1980: Walsh J W; Markesbery W R
Histological features of congenital lipomas of the lower spinal canal.
Journal of neurosurgery 1980;52(4):564-9.
1980: Markesbery W R; Leung P K; Butterfield D A
Spin label and biochemical studies of erythrocyte membranes in Alzheimer's disease.
Journal of the neurological sciences 1980;45(2-3):323-30.
1980: Markesbery W R; Walsh J W; Frye M D
Ultrastructural study of the medulloblastoma in tissue culture.
Journal of neuropathology and experimental neurology 1980;39(1):30-41.
1979: Markesbery W R
Lactic acidemia, mitochondrial myopathy, and basal ganglia calcification.
Neurology 1979;29(7):1057-60.
1979: Markesbery W R; Challa V R
Electron microscopic findings in primitive neuroectodermal tumors of the cerebrum.
Cancer 1979;44(1):141-7.
1979: Butterfield D A; Leung P K; Markesbery W R; Barbeau A
Evidence for an altered physical state of membrane proteins in erythrocytes in Friedreich's ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1979;6(2):295-8.
1979: Butterfield D A; Purdy M J; Markesbery W R
Electron spin resonance, hematological, and deformability studies of erythrocytes from patients with Huntington's disease.
Biochimica et biophysica acta 1979;551(2):452-8.
1979: McComb R D; Markesbery W R; O'Connor W N
Fatal neonatal nemaline myopathy with multiple congenital anomalies.
The Journal of pediatrics 1979;94(1):47-51.
1979: Butterfield D A; Markesbery W R
Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological diseases: Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and Duchenne muscular dystrophy.
Transactions of the American Neurological Association 1979;104():57-60.
1978: Moxley R T; Griggs R C; Markesbery W R; Vangelder V
Metabolic implications of distal atrophy. Carbohydrate metabolism in centronuclear myopathy.
Journal of the neurological sciences 1978;39(2-3):247-59.
1978: Baumann R J; Markesbery W R
Juvenile amaurotic idiocy (neuronal ceroid lipofuscinosis) and lymphocyte fingerprint profiles.
Annals of neurology 1978;4(6):531-6.
1978: Markesbery W R; Brooks W H; Gupta G D; Young A B
Treatment for patients with cerebral metastases.
Archives of neurology 1978;35(11):754-6.
1978: Brooks W H; Markesbery W R; Gupta G D; Roszman T L
Relationship of lymphocyte invasion and survival of brain tumor patients.
Annals of neurology 1978;4(3):219-24.
1978: Challa V R; Markesbery W R
Infratentorial neuroepithelial cyst (colloid cyst). Case report.
Journal of neurosurgery 1978;49(3):457-9.
1978: Challa V R; Markesbery W R; Baumann R J; Noonan J A
Lactic acidosis associated with cerebellar vermal atrophy and cardiomyopathy.
Neuropädiatrie 1978;9(3):277-84.
1978: Butterfield D A; Oeswein J Q; Prunty M E; Hisle K C; Markesbery W R
Increased sodium plus potassium adenosine triphosphatase activity in erythrocyte membranes in Huntington's disease.
Annals of neurology 1978;4(1):60-2.
1978: McIntosh G C; Jameson H D; Markesbery W R
Huntington disease associated with Alzheimer disease.
Annals of neurology 1978;3(6):545-8.
1978: Roszman T L; Brooks W H; Markesbery W R; Bigner D D
General immunocompetence of rats bearing avian sarcoma virus-induced intracranial tumors.
Cancer research 1978;38(1):74-7.
1978: Baumann R J; Markesbery W R
Juvenile amaurotic idiocy and lymphocyte inclusions.
Transactions of the American Neurological Association 1978;103():92-5.
1978: Butterfield D A; Braden M L; Markesbery W R
Erythrocyte membrane alterations in Huntington disease: effects of gamma-aminobutyric acid.
Journal of supramolecular structure 1978;9(1):125-30.
1977: Shield L K; Coleman T L; Markesbery W R
Methyl bromide intoxication: neurologic features, including simulation of Reye syndrome.
Neurology 1977;27(10):959-62.
1977: Markesbery W R; Butterfield D A
Scanning electron microscopy studies of erythrocytes in Huntington's disease.
Biochemical and biophysical research communications 1977;78(2):560-4.
1977: Challa V R; Jona J Z; Markesbery W R
Ultrastructural observations of the myenteric plexus of the pylorus in infantile hypertrophic pyloric stenosis.
The American journal of pathology 1977;88(2):309-22.
1977: Markesbery W R; Griggs R C; Herr B
Distal myopathy: electron microscopic and histochemical studies.
Neurology 1977;27(8):727-35.
1977: Butterfield D A; Oeswein J Q; Markesbery W R
Electron spin resonance study of membrane protein alterations in erythrocytes in Huntington's disease.
Nature 1977;267(5610):453-5.
1977: Banta R G; Markesbery W R
Elevated manganese levels associated with dementia and extrapyramidal signs.
Neurology 1977;27(3):213-6.
1977: McAllister R G; Markesbery W R; Ware R W; Howell S M
Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade.
Annals of neurology 1977;1(2):160-6.
1977: Markesbery W R
Pathology of muscular dystrophy and related disorders.
Advances in neurology 1977;17():175-95.
1976: Markesbery W R; Shield L K; Egel R T; Jameson H D
Late-infantile neuronal ceroid-lipofuscinosis. An ultrastructural study of lymphocyte inclusions.
Archives of neurology 1976;33(9):630-5.
1976: Markesbery W R; Brooks W H; Milsow L; Mortara R H
Ultrastructural study of the pineal germinoma in vivo and in vitro.
Cancer 1976;37(1):327-37.
1976: McAllister R G; Markesbery W R; Ware R W; Howell S M
Suppression of essential tremor by propranolol: correlation of effect with intensity of beta-adrenergic blockade.
Transactions of the American Neurological Association 1976;101():267-9.
1975: Griggs R C; Markesbery W R; Bauman A W; Callerame M L
Perivascular hemosiderin deposition in muscle in Waldenström's macroglobulinemia.
Journal of the neurological sciences 1975;25(2):153-63.
1975: VanDyke D H; Griggs R C; Markesbery W; Dimauro S
Hereditary carnitine deficiency of muscle.
Neurology 1975;25(2):154-9.
1974: Markesbery W R; McQuillen M P; Procopis P G; Harrison A R; Engel A G
Muscle carnitine deficiency. Association with lipid myopathy, vacuolar neuropathy, and vacuolated leukocytes.
Archives of neurology 1974;31(5):320-4.
1974: Iannaccone S T; Griggs R C; Markesbery W R; Joynt R J
Familial progressive external ophthalmoplegia and ragged-red fibers.
Neurology 1974;24(11):1033-8.
1974: Goldblatt D; Markesbery W; Reeves A G
Recurrent hemichorea following striatal lesions.
Archives of neurology 1974;31(1):51-4.
1974: Markesbery W R; Griggs R C; Leach R P; Lapham L W
Late onset hereditary distal myopathy.
Neurology 1974;24(2):127-34.
1974: Markesbery W R; Lapham L W
A correlated light and electron microscopic study of the early phase of growth in vitro of human fetal cerebellar and cerebral cortex.
Journal of neuropathology and experimental neurology 1974;33(1):113-27.
1973: Griggs R C; Markesbery W R; Condemi J J
Cerebral mass due to sarcoidosis. Regression during corticosteroid therapy.
Neurology 1973;23(9):981-9.
1973: Defendini R; Markesbery W R; Mastri A R; Duffy P E
Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology.
Journal of the neurological sciences 1973;20(1):7-23.
1973: Markesbery W R; McDonald J V
Diencephalic syndrome. Long-term survival.
American journal of diseases of children (1960) 1973;125(1):123-5.
1973: Markesbery W R; Duffy P E; Cowen D
Granular cell tumors of the central nervous system.
Journal of neuropathology and experimental neurology 1973;32(1):92-109.
1972: Carmel P W; Markesbery W R
Early descriptions of the Arnold-Chiari malformation. The contribution of John Cleland.
Journal of neurosurgery 1972;37(5):543-7.
1971: Nordgren R E; Markesbery W R; Fukuda K; Reeves A G
Seven cases of cerebromedullospinal disconnection: the "locked-in" syndrome.
Neurology 1971;21(11):1140-8.
1971: Lapham L W; Markesbery W R
Human fetal cerebellar cortex: organization and maturation of cells in vitro.
Science (New York, N.Y.) 1971;173(999):829-32.
1971: Mendell J R; Markesbery W R
Neuronal intracytoplasmic hyaline inclusions.
Journal of neuropathology and experimental neurology 1971;30(2):233-9.
1971: Lapham L W; Markesbery W R
In vitro studies of normal newborn rat cerebellum using a chemically defined tissue culture medium.
Journal of neuropathology and experimental neurology 1971;30(1):126-7.
1970: Duffy P E; Markesbery W R
Granulated vesicles in sympathetic nerve endings in the pineal gland: observations on the effects of pharmacologic agents by electron microscopy.
The American journal of anatomy 1970;128(1):97-115.
1969: Carmel P W; Markesbery W R
Arnold-Chiari malformation in an elderly woman.
Archives of neurology 1969;21(3):258-62.
1966: Wilson C B; Markesbery W
Traumatic carotid-cavernous fistula with fatal epistaxis. Report of a case.
Journal of neurosurgery 1966;24(1):111-3.
1964: MARKESBERY W; WILSON C B
EMULSIFIED PANTOPAQUE FOR CEREBRAL VENTRICULOGRAPHY.
Surgical forum 1964;15():419-21.
1963: GILLILAN L A; MARKESBERY W R
ARTERIOVENOUS SHUNTS IN THE BLOOD SUPPLY TO THE BRAINS OF SOME COMMON LABORATORY ANIMALS--WITH SPECIAL ATTENTION TO THE RETE MIRABILE CONJUGATUM IN THE CAT.
The Journal of comparative neurology 1963;121():305-11.
1961: KNISELY W H; BLANDING J D; ALAVI S M; MARKESBERY W R; BLEGEN B L
Distributions and growth rates of injected VX2 tumor cells in rabbits.
Angiology 1961;12():535-7.
1961: ARCHDEACON J W; MARKESBERY W R; BINFORD B R
Bone marrow cellularity and Na and K levels in fasting and inanition after bile duct ligation.
The American journal of physiology 1961;200():1207-10.

Sign-in to see more